Decrease of prothrombin level during thrombolysis in acute myocardium infarction.

Korolova, Daria S; Parkhomenko, Alexander M; Chernyshenko, Volodymyr; Chernyshenko, Tamara M; Druzhyna, Nadiya M; Hornytska, Olha V; Platonova, Tetyana M

Korolova, Daria S; Parkhomenko, Alexander M; Chernyshenko, Volodymyr; Chernyshenko, Tamara M; Druzhyna, Nadiya M; Hornytska, Olha V; Platonova, Tetyana M.

Afiliação

Korolova DS; Palladin Institute of Biochemistry, National Academy of Science of Ukraine.
Parkhomenko AM; State Institutional Scientific Center The M.D. Strazhesko Institute of Cardiology, Clinical and Regenerative Medicine of The National Academy of Medical Sciences of Ukraine.
Chernyshenko V; Palladin Institute of Biochemistry, National Academy of Science of Ukraine.
Chernyshenko TM; Palladin Institute of Biochemistry, National Academy of Science of Ukraine.
Druzhyna NM; Palladin Institute of Biochemistry, National Academy of Science of Ukraine.
Hornytska OV; Palladin Institute of Biochemistry, National Academy of Science of Ukraine.
Platonova TM; Palladin Institute of Biochemistry, National Academy of Science of Ukraine.

Acta Biochim Pol ; 70(4): 991-995, 2023 Nov 27.

Article em En | MEDLINE | ID: mdl-38011253

Assuntos

Infarto do Miocárdio; Protrombina; Humanos; Protrombina/metabolismo; Protrombina/uso terapêutico; Heparina de Baixo Peso Molecular/uso terapêutico; Trombina; Fator Xa/uso terapêutico; Infarto do Miocárdio/tratamento farmacológico; Heparina/farmacologia; Heparina/uso terapêutico; Estreptoquinase/uso terapêutico; Estreptoquinase/farmacologia; Terapia Trombolítica; Anticoagulantes/uso terapêutico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protrombina / Infarto do Miocárdio Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google